312 related articles for article (PubMed ID: 24361528)
1. Discoidin domain receptors in disease.
Borza CM; Pozzi A
Matrix Biol; 2014 Feb; 34():185-92. PubMed ID: 24361528
[TBL] [Abstract][Full Text] [Related]
2. Novel insights into the role of Discoidin domain receptor 2 (DDR2) in cancer progression: a new avenue of therapeutic intervention.
Trono P; Ottavi F; Rosano' L
Matrix Biol; 2024 Jan; 125():31-39. PubMed ID: 38081526
[TBL] [Abstract][Full Text] [Related]
3. Discoidin Domain Receptor-Driven Gene Signatures as Markers of Patient Response to Anti-PD-L1 Immune Checkpoint Therapy.
You S; Kim M; Hoi XP; Lee YC; Wang L; Spetzler D; Abraham J; Magee D; Jain P; Galsky MD; Chan KS; Theodorescu D
J Natl Cancer Inst; 2022 Oct; 114(10):1380-1391. PubMed ID: 35918812
[TBL] [Abstract][Full Text] [Related]
4. Discoidin Domain Receptor 1 is a therapeutic target for neurodegenerative diseases.
Fowler AJ; Hebron M; Balaraman K; Shi W; Missner AA; Greenzaid JD; Chiu TL; Ullman C; Weatherdon E; Duka V; Torres-Yaghi Y; Pagan FL; Liu X; Ressom H; Ahn J; Wolf C; Moussa C
Hum Mol Genet; 2020 Oct; 29(17):2882-2898. PubMed ID: 32776088
[TBL] [Abstract][Full Text] [Related]
5. Design, synthesis, and biological evaluation of novel discoidin domain receptor inhibitors for the treatment of lung adenocarcinoma and pulmonary fibrosis.
Liu S; Li X; Chen C; Lin X; Zuo W; Peng C; Jiang Q; Huang W; He G
Eur J Med Chem; 2024 Feb; 265():116100. PubMed ID: 38171149
[TBL] [Abstract][Full Text] [Related]
6. Research progress of DDR1 inhibitors in the treatment of multiple human diseases.
Liu M; Zhang J; Li X; Wang Y
Eur J Med Chem; 2024 Mar; 268():116291. PubMed ID: 38452728
[TBL] [Abstract][Full Text] [Related]
7. DDR1-targeted therapies: current limitations and future potential.
Wu D; Ding Z; Lu T; Chen Y; Zhang F; Lu S
Drug Discov Today; 2024 May; 29(5):103975. PubMed ID: 38580164
[TBL] [Abstract][Full Text] [Related]
8. Discoidin domain receptors: a proteomic portrait.
Iwai LK; Luczynski MT; Huang PH
Cell Mol Life Sci; 2014 Sep; 71(17):3269-79. PubMed ID: 24705941
[TBL] [Abstract][Full Text] [Related]
9. Discoidin domain receptor functions in physiological and pathological conditions.
Leitinger B
Int Rev Cell Mol Biol; 2014; 310():39-87. PubMed ID: 24725424
[TBL] [Abstract][Full Text] [Related]
10. Discoidin domain receptor 1 (DDR1) kinase as target for structure-based drug discovery.
Kothiwale S; Borza CM; Lowe EW; Pozzi A; Meiler J
Drug Discov Today; 2015 Feb; 20(2):255-61. PubMed ID: 25284748
[TBL] [Abstract][Full Text] [Related]
11. Discoidin Domain Receptors: Potential Actors and Targets in Cancer.
Rammal H; Saby C; Magnien K; Van-Gulick L; Garnotel R; Buache E; El Btaouri H; Jeannesson P; Morjani H
Front Pharmacol; 2016; 7():55. PubMed ID: 27014069
[TBL] [Abstract][Full Text] [Related]
12. Small molecule discoidin domain receptor kinase inhibitors and potential medical applications.
Li Y; Lu X; Ren X; Ding K
J Med Chem; 2015 Apr; 58(8):3287-301. PubMed ID: 25569119
[TBL] [Abstract][Full Text] [Related]
13. Structural mechanisms determining inhibition of the collagen receptor DDR1 by selective and multi-targeted type II kinase inhibitors.
Canning P; Tan L; Chu K; Lee SW; Gray NS; Bullock AN
J Mol Biol; 2014 Jun; 426(13):2457-70. PubMed ID: 24768818
[TBL] [Abstract][Full Text] [Related]
14. The Role of Discoidin Domain Receptor 1 in Inflammation, Fibrosis and Renal Disease.
Dorison A; Dussaule JC; Chatziantoniou C
Nephron; 2017; 137(3):212-220. PubMed ID: 28743124
[TBL] [Abstract][Full Text] [Related]
15. Discoidin domain receptor 2 signaling networks and therapy in lung cancer.
Payne LS; Huang PH
J Thorac Oncol; 2014 Jun; 9(6):900-4. PubMed ID: 24828669
[TBL] [Abstract][Full Text] [Related]
16. Discoidin domain receptor-1 and periostin: new players in chronic kidney disease.
Alfieri C; Kavvadas P; Simonini P; Ikehata M; Dussaule JC; Chadjichristos CE; Rastaldi MP; Messa P; Chatziantoniou C
Nephrol Dial Transplant; 2015 Dec; 30(12):1965-71. PubMed ID: 25829327
[TBL] [Abstract][Full Text] [Related]
17. Searching novel diagnostic markers and targets for therapy of CKD.
Kavvadas P; Dussaule JC; Chatziantoniou C
Kidney Int Suppl (2011); 2014 Nov; 4(1):53-57. PubMed ID: 26312150
[TBL] [Abstract][Full Text] [Related]
18. The discoidin domain receptor tyrosine kinases are activated by collagen.
Vogel W; Gish GD; Alves F; Pawson T
Mol Cell; 1997 Dec; 1(1):13-23. PubMed ID: 9659899
[TBL] [Abstract][Full Text] [Related]
19. Tyrosine kinase discoidin domain receptors DDR1 and DDR2 are coordinately deregulated in triple-negative breast cancer.
Toy KA; Valiathan RR; Núñez F; Kidwell KM; Gonzalez ME; Fridman R; Kleer CG
Breast Cancer Res Treat; 2015 Feb; 150(1):9-18. PubMed ID: 25667101
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
